InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the full record of transactions filed by Robb Gary Charles, Directeur Commercial. Insider active across 2 companies, notably Corcept Therapeutics INC. Aggregated, 8 filings have been recorded. Total volume traded: €925k. The latest transaction was filed on 13 May 2026 — Don. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
05,300 shares0
Common Stock
SEC:0001193125-26-227411·
05,300 shares0
Common Stock
SEC:0001193125-26-227411:0·
€532,77628,745 shares@ €18.53460.0088% mcap46.2% of flow
Common Stock
SEC:0000899243-22-018862:0·
€168,1867,512 shares@ €22.3890.0028% mcap14.6% of flow
Common Stock
SEC:0000899243-22-011614:0·
€112,1286,341 shares@ €17.6830.0030% mcap24.9% of flow
Common Stock
SEC:0000899243-21-036139·
€112,1286,341 shares@ €17.6830.0019% mcap9.7% of flow
Common Stock
SEC:0000899243-21-036139:0·
€339,072148,148 shares@ €2.28870.0092% mcap75.1% of flow
Common Stock
SEC:0000899243-21-034772·
€339,072148,148 shares@ €2.28870.0056% mcap29.4% of flow
Common Stock
SEC:0000899243-21-034772:0·
8 of 8 declarations
About Robb Gary Charles
Gary Charles Robb is the Chief Business Officer at CORCEPT THERAPEUTICS INC. He is responsible for the company's business strategy, aiming to expand its operations and increase market share. With strong experience in business development, he plays a key role in identifying new opportunities and optimizing Corcept's operations.
